{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:56:50Z","timestamp":1791601010828,"version":"4.3.4"},"reference-count":46,"publisher":"National Academy of Sciences","issue":"19","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":183,"URL":"https:\/\/www.pnas.org\/site\/aboutpnas\/licenses.xhtml"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["TLGM-NDD"],"award-info":[{"award-number":["TLGM-NDD"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["TLGM-NDD"],"award-info":[{"award-number":["TLGM-NDD"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2019,5,7]]},"abstract":"<jats:p>White matter abnormalities are a nearly universal pathological feature of neurodegenerative disorders including Huntington disease (HD). A long-held assumption is that this white matter pathology is simply a secondary outcome of the progressive neuronal loss that manifests with advancing disease. Using a mouse model of HD, here we show that white matter and myelination abnormalities are an early disease feature appearing before the manifestation of any behavioral abnormalities or neuronal loss. We further show that selective inactivation of mutant huntingtin (mHTT) in the NG2+ oligodendrocyte progenitor cell population prevented myelin abnormalities and certain behavioral deficits in HD mice. Strikingly, the improvements in behavioral outcomes were seen despite the continued expression of mHTT in nonoligodendroglial cells including neurons, astrocytes, and microglia. Using RNA-seq and ChIP-seq analyses, we implicate a pathogenic mechanism that involves enhancement of polycomb repressive complex 2 (PRC2) activity by mHTT in the intrinsic oligodendroglial dysfunction and myelination deficits observed in HD. Our findings challenge the long-held dogma regarding the etiology of white matter pathology in HD and highlight the contribution of epigenetic mechanisms to the observed intrinsic oligodendroglial dysfunction. Our results further suggest that ameliorating white matter pathology and oligodendroglial dysfunction may be beneficial for HD.<\/jats:p>","DOI":"10.1073\/pnas.1818042116","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T16:44:06Z","timestamp":1556037846000},"page":"9622-9627","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":128,"title":["Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease"],"prefix":"10.1073","volume":"116","author":[{"given":"Costanza","family":"Ferrari Bardile","sequence":"first","affiliation":[{"name":"Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, 138648 Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garcia-Miralles","sequence":"additional","affiliation":[{"name":"Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, 138648 Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Caron","sequence":"additional","affiliation":[{"name":"Centre for Molecular Medicine and Therapeutics, BC Children\u2019s Hospital Research Institute, University of British Columbia, Vancouver BC V5Z 4H4, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala Arul","family":"Rayan","sequence":"additional","affiliation":[{"name":"Computational and Systems Biology, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), 138672 Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Langley","sequence":"additional","affiliation":[{"name":"Centre for Computational Biology, Duke-NUS Medical School, 169857 Singapore;"},{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, 636921 Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8589-2938","authenticated-orcid":false,"given":"Nathan","family":"Harmston","sequence":"additional","affiliation":[{"name":"Centre for Computational Biology, Duke-NUS Medical School, 169857 Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Rondelli","sequence":"additional","affiliation":[{"name":"The Medical Research Council Centre for Regenerative Medicine and Multiple Sclerosis Society Edinburgh Centre, Edinburgh bioQuarter, The University of Edinburgh, Edinburgh EH16 4UU, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy Tang Yi","family":"Teo","sequence":"additional","affiliation":[{"name":"Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, 138648 Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Waltl","sequence":"additional","affiliation":[{"name":"Centre for Molecular Medicine and Therapeutics, BC Children\u2019s Hospital Research Institute, University of British Columbia, Vancouver BC V5Z 4H4, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Centre for Molecular Medicine and Therapeutics, BC Children\u2019s Hospital Research Institute, University of British Columbia, Vancouver BC V5Z 4H4, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Gyu","family":"Bae","sequence":"additional","affiliation":[{"name":"Singapore Bioimaging Consortium (SBIC), Agency for Science, Technology and Research (A*STAR), 138667 Singapore;"},{"name":"Department of Life Sciences, Yeungnam University, Gyeongsan, Gyeongsangbuk-do 38541, South Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangyong","family":"Jung","sequence":"additional","affiliation":[{"name":"Singapore Bioimaging Consortium (SBIC), Agency for Science, Technology and Research (A*STAR), 138667 Singapore;"},{"name":"Department of Physiology, National University of Singapore, 117597 Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Williams","sequence":"additional","affiliation":[{"name":"The Medical Research Council Centre for Regenerative Medicine and Multiple Sclerosis Society Edinburgh Centre, Edinburgh bioQuarter, The University of Edinburgh, Edinburgh EH16 4UU, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Prabhakar","sequence":"additional","affiliation":[{"name":"Computational and Systems Biology, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), 138672 Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Petretto","sequence":"additional","affiliation":[{"name":"Centre for Computational Biology, Duke-NUS Medical School, 169857 Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[{"name":"Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, 138648 Singapore;"},{"name":"Centre for Molecular Medicine and Therapeutics, BC Children\u2019s Hospital Research Institute, University of British Columbia, Vancouver BC V5Z 4H4, Canada;"},{"name":"Department of Medicine, National University of Singapore, 117597 Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-0976","authenticated-orcid":false,"given":"Mahmoud A.","family":"Pouladi","sequence":"additional","affiliation":[{"name":"Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, 138648 Singapore;"},{"name":"Department of Physiology, National University of Singapore, 117597 Singapore;"},{"name":"Department of Medicine, National University of Singapore, 117597 Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease","volume":"47","author":"de la Monte SM","year":"1988","unstructured":"SM de la Monte, JP Vonsattel, Jr EP Richardson, Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease. J Neuropathol Exp Neurol 47, 516\u2013525 (1988).","journal-title":"J Neuropathol Exp Neurol"},{"key":"e_1_3_4_2_2","first-page":"553","article-title":"The topographic distribution of brain atrophy in Huntington\u2019s disease and progressive supranuclear palsy","volume":"85","author":"Mann DMA","year":"1993","unstructured":"DMA Mann, R Oliver, JS Snowden, The topographic distribution of brain atrophy in Huntington\u2019s disease and progressive supranuclear palsy. Acta Neuropathol 85, 553\u2013559 (1993).","journal-title":"Acta Neuropathol"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington\u2019s disease: Pathogenesis and treatment implications","volume":"32","author":"Bartzokis G","year":"2007","unstructured":"G Bartzokis, , Myelin breakdown and iron changes in Huntington\u2019s disease: Pathogenesis and treatment implications. Neurochem Res 32, 1655\u20131664 (2007).","journal-title":"Neurochem Res"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pscychresns.2005.05.011","article-title":"Regional white matter change in pre-symptomatic Huntington\u2019s disease: A diffusion tensor imaging study","volume":"140","author":"Reading SAJ","year":"2005","unstructured":"SAJ Reading, , Regional white matter change in pre-symptomatic Huntington\u2019s disease: A diffusion tensor imaging study. Psychiatry Res 140, 55\u201362 (2005).","journal-title":"Psychiatry Res"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.20979","article-title":"Diffusion tensor imaging in presymptomatic and early Huntington\u2019s disease: Selective white matter pathology and its relationship to clinical measures","volume":"21","author":"Rosas HD","year":"2006","unstructured":"HD Rosas, , Diffusion tensor imaging in presymptomatic and early Huntington\u2019s disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord 21, 1317\u20131325 (2006).","journal-title":"Mov Disord"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.nicl.2018.01.029","article-title":"Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease","volume":"20","author":"Rosas HD","year":"2018","unstructured":"HD Rosas, , Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease. Neuroimage Clin 20, 236\u2013242 (2018).","journal-title":"Neuroimage Clin"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to dysmyelination in experimental models of Huntington\u2019s disease","volume":"31","author":"Xiang Z","year":"2011","unstructured":"Z Xiang, , Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to dysmyelination in experimental models of Huntington\u2019s disease. J Neurosci 31, 9544\u20139553 (2011).","journal-title":"J Neurosci"},{"key":"e_1_3_4_8_2","first-page":"2621","article-title":"Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease","volume":"25","author":"Teo RTY","year":"2016","unstructured":"RTY Teo, , Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease. Hum Mol Genet 25, 2621\u20132632 (2016).","journal-title":"Hum Mol Genet"},{"key":"e_1_3_4_9_2","article-title":"Laquinimod treatment improves myelination deficits at the transcriptional and ultrastructural levels in the YAC128 mouse model of Huntington disease","author":"Garcia-Miralles M","year":"2018","unstructured":"M Garcia-Miralles, , Laquinimod treatment improves myelination deficits at the transcriptional and ultrastructural levels in the YAC128 mouse model of Huntington disease. Mol Neurobiol, 2018).","journal-title":"Mol Neurobiol"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi SJ","year":"2009","unstructured":"SJ Tabrizi, , Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol; TRACK-HD investigators 8, 791\u2013801 (2009).","journal-title":"Lancet Neurol"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington\u2019s disease decades before diagnosis: The predict-HD study","volume":"79","author":"Paulsen JS","year":"2008","unstructured":"JS Paulsen, , Detection of Huntington\u2019s disease decades before diagnosis: The predict-HD study. J Neurol Neurosurg Psychiatry; Predict-HD Investigators and Coordinators of the Huntington Study Group 79, 874\u2013880 (2008).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2011.03.018","article-title":"Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease","volume":"43","author":"Carroll JB","year":"2011","unstructured":"JB Carroll, , Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease. Neurobiol Dis 43, 257\u2013265 (2011).","journal-title":"Neurobiol Dis"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature09614","article-title":"Myelination and support of axonal integrity by glia","volume":"468","author":"Nave K-A","year":"2010","unstructured":"K-A Nave, Myelination and support of axonal integrity by glia. Nature 468, 244\u2013252 (2010).","journal-title":"Nature"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray M","year":"2008","unstructured":"M Gray, , Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28, 6182\u20136195 (2008).","journal-title":"J Neurosci"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi MA","year":"2012","unstructured":"MA Pouladi, , Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum Mol Genet 21, 2219\u20132232 (2012).","journal-title":"Hum Mol Genet"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0166-2236(00)01691-X","article-title":"The oligodendrocyte precursor cell in health and disease","volume":"24","author":"Levine JM","year":"2001","unstructured":"JM Levine, R Reynolds, JW Fawcett, The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24, 39\u201347 (2001).","journal-title":"Trends Neurosci"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz S","year":"2010","unstructured":"S Heinz, , Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38, 576\u2013589 (2010).","journal-title":"Mol Cell"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1242\/dev.128.14.2723","article-title":"Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor","volume":"128","author":"Qi Y","year":"2001","unstructured":"Y Qi, , Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development 128, 2723\u20132733 (2001).","journal-title":"Development"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1242\/dev.029447","article-title":"Human oligodendrocytes from embryonic stem cells: Conserved SHH signaling networks and divergent FGF effects","volume":"136","author":"Hu BY","year":"2009","unstructured":"BY Hu, ZW Du, XJ Li, M Ayala, SC Zhang, Human oligodendrocytes from embryonic stem cells: Conserved SHH signaling networks and divergent FGF effects. Development 136, 1443\u20131452 (2009).","journal-title":"Development"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang Y","year":"2014","unstructured":"Y Zhang, , An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34, 11929\u201311947 (2014).","journal-title":"J Neurosci"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","article-title":"ChEA: Transcription factor regulation inferred from integrating genome-wide ChIP-X experiments","volume":"26","author":"Lachmann A","year":"2010","unstructured":"A Lachmann, , ChEA: Transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438\u20132444 (2010).","journal-title":"Bioinformatics"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato C","year":"2003","unstructured":"C Zuccato, , Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35, 76\u201383 (2003).","journal-title":"Nat Genet"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1523\/JNEUROSCI.2768-10.2011","article-title":"The RE1 binding protein REST regulates oligodendrocyte differentiation","volume":"31","author":"Dewald LE","year":"2011","unstructured":"LE Dewald, JP Rodriguez, JM Levine, The RE1 binding protein REST regulates oligodendrocyte differentiation. J Neurosci 31, 3470\u20133483 (2011).","journal-title":"J Neurosci"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron R","year":"2011","unstructured":"R Margueron, D Reinberg, The Polycomb complex PRC2 and its mark in life. Nature 469, 343\u2013349 (2011).","journal-title":"Nature"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1634\/stemcells.2008-0121","article-title":"Differentiation of neural stem cells into oligodendrocytes: Involvement of the polycomb group protein Ezh2","volume":"26","author":"Sher F","year":"2008","unstructured":"F Sher, , Differentiation of neural stem cells into oligodendrocytes: Involvement of the polycomb group protein Ezh2. Stem Cells 26, 2875\u20132883 (2008).","journal-title":"Stem Cells"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/hmg\/ddp524","article-title":"Huntingtin facilitates polycomb repressive complex 2","volume":"19","author":"Seong I","year":"2010","unstructured":"I Seong, , Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet 19, 573\u2013583 (2010).","journal-title":"Hum Mol Genet"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"25828","DOI":"10.1038\/srep25828","article-title":"The transcriptome of mouse central nervous system myelin","volume":"6","author":"Thakurela S","year":"2016","unstructured":"S Thakurela, , The transcriptome of mouse central nervous system myelin. Sci Rep 6, 25828 (2016).","journal-title":"Sci Rep"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1523\/JNEUROSCI.23-27-09229.2003","article-title":"The transmembrane semaphorin Sema4D\/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion","volume":"23","author":"Moreau-Fauvarque C","year":"2003","unstructured":"C Moreau-Fauvarque, , The transmembrane semaphorin Sema4D\/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci 23, 9229\u20139239 (2003).","journal-title":"J Neurosci"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1017\/S003329171300247X","article-title":"The neuroanatomy of subthreshold depressive symptoms in Huntington\u2019s disease: A combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study","volume":"44","author":"Sprengelmeyer R","year":"2014","unstructured":"R Sprengelmeyer, , The neuroanatomy of subthreshold depressive symptoms in Huntington\u2019s disease: A combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study. Psychol Med 44, 1867\u20131878 (2014).","journal-title":"Psychol Med"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1038\/tp.2012.34","article-title":"A putative functional role for oligodendrocytes in mood regulation","volume":"2","author":"Edgar N","year":"2012","unstructured":"N Edgar, E Sibille, A putative functional role for oligodendrocytes in mood regulation. Transl Psychiatry 2, e109 (2012).","journal-title":"Transl Psychiatry"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamapsychiatry.2014.189","article-title":"Myelination and oligodendrocyte functions in psychiatric diseases","volume":"71","author":"Nave K-A","year":"2014","unstructured":"K-A Nave, H Ehrenreich, Myelination and oligodendrocyte functions in psychiatric diseases. JAMA Psychiatry 71, 582\u2013584 (2014).","journal-title":"JAMA Psychiatry"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1038\/s41598-017-05507-6","article-title":"Subcortical volume and white matter integrity abnormalities in major depressive disorder: Findings from UK Biobank imaging data","volume":"7","author":"Shen X","year":"2017","unstructured":"X Shen, , Subcortical volume and white matter integrity abnormalities in major depressive disorder: Findings from UK Biobank imaging data. Sci Rep 7, 5547 (2017).","journal-title":"Sci Rep"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuron.2015.10.046","article-title":"Genetic and stress-induced loss of NG2 glia triggers emergence of depressive-like behaviors through reduced secretion of FGF2","volume":"88","author":"Birey F","year":"2015","unstructured":"F Birey, , Genetic and stress-induced loss of NG2 glia triggers emergence of depressive-like behaviors through reduced secretion of FGF2. Neuron 88, 941\u2013956 (2015).","journal-title":"Neuron"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","article-title":"White matter lesions in Parkinson disease","volume":"7","author":"Bohnen NI","year":"2011","unstructured":"NI Bohnen, RL Albin, White matter lesions in Parkinson disease. Nat Rev Neurol 7, 229\u2013236 (2011).","journal-title":"Nat Rev Neurol"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nbd.2014.01.013","article-title":"White matter connectivity reflects clinical and cognitive status in Huntington\u2019s disease","volume":"65","author":"Poudel GR","year":"2014","unstructured":"GR Poudel, , White matter connectivity reflects clinical and cognitive status in Huntington\u2019s disease. Neurobiol Dis 65, 180\u2013187 (2014).","journal-title":"Neurobiol Dis"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.conb.2004.10.003","article-title":"Functional diversity and specificity of neostriatal interneurons","volume":"14","author":"Tepper JM","year":"2004","unstructured":"JM Tepper, JP Bolam, Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 14, 685\u2013692 (2004).","journal-title":"Curr Opin Neurobiol"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","article-title":"Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes","volume":"85","author":"Huang B","year":"2015","unstructured":"B Huang, , Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes. Neuron 85, 1212\u20131226 (2015).","journal-title":"Neuron"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.1523\/JNEUROSCI.1069-12.2012","article-title":"Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS","volume":"32","author":"Koenning M","year":"2012","unstructured":"M Koenning, , Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS. J Neurosci 32, 12528\u201312542 (2012).","journal-title":"J Neurosci"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim KH","year":"2016","unstructured":"KH Kim, CWM Roberts, Targeting EZH2 in cancer. Nat Med 22, 128\u2013134 (2016).","journal-title":"Nat Med"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.stem.2018.11.010","article-title":"Human ESC-derived chimeric mouse models of Huntington\u2019s disease reveal cell-intrinsic defects in glial progenitor cell differentiation","volume":"24","author":"Osipovitch M","year":"2019","unstructured":"M Osipovitch, , Human ESC-derived chimeric mouse models of Huntington\u2019s disease reveal cell-intrinsic defects in glial progenitor cell differentiation. Cell Stem Cell 24, 107\u2013122.e7 (2019).","journal-title":"Cell Stem Cell"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/embor.2010.182","article-title":"Is Huntington disease a developmental disorder?","volume":"11","author":"Humbert S","year":"2010","unstructured":"S Humbert, Is Huntington disease a developmental disorder? EMBO Rep 11, 899 (2010).","journal-title":"EMBO Rep"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2016.09.006","article-title":"Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington\u2019s disease","volume":"96","author":"Arteaga-Bracho EE","year":"2016","unstructured":"EE Arteaga-Bracho, , Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington\u2019s disease. Neurobiol Dis 96, 144\u2013155 (2016).","journal-title":"Neurobiol Dis"},{"key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"e64368","DOI":"10.1371\/journal.pone.0064368","article-title":"Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis","volume":"8","author":"Nguyen GD","year":"2013","unstructured":"GD Nguyen, S Gokhan, AE Molero, MF Mehler, Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis. PLoS One 8, e64368 (2013).","journal-title":"PLoS One"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1523\/JNEUROSCI.21-03-00920.2001","article-title":"The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells","volume":"21","author":"Schneider S","year":"2001","unstructured":"S Schneider, , The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells. J Neurosci 21, 920\u2013933 (2001).","journal-title":"J Neurosci"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","article-title":"Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington\u2019s disease mutation","volume":"20","author":"Ribchester RR","year":"2004","unstructured":"RR Ribchester, , Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington\u2019s disease mutation. Eur J Neurosci 20, 3092\u20133114 (2004).","journal-title":"Eur J Neurosci"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","first-page":"D19","DOI":"10.1093\/nar\/gkq1019","article-title":"The sequence read archive","volume":"39","author":"Leinonen R","year":"2011","unstructured":"R Leinonen, H Sugawara, M Shumway, The sequence read archive. Nucleic Acids Res 39, D19\u2013D21 (2011).","journal-title":"Nucleic Acids Res"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1818042116","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1818042116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T15:15:55Z","timestamp":1654614955000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1818042116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":46,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019,5,7]]}},"alternative-id":["10.1073\/pnas.1818042116"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1818042116","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,23]]},"assertion":[{"value":"2019-04-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}